We are on a mission to make a meaningful impact on the lives of patients with blood-related cancers.
At CTI, we are resolute in our commitment to deliver new medicines to patients with blood-related cancers who have limited treatment options. With our deep hematology-oncology expertise and sense of urgency, we are motivated to shift the treatment paradigm for blood-related cancers. By identifying specific patient communities currently underserved by existing therapies and uncovering the scientific factors driving their diseases, we aim to advance the development of therapies that are potentially less toxic and more effective at treating patients.

WE ARE FOCUSED ON THE ACQUISITION, DEVELOPMENT AND COMMERCIALIZATION OF NOVEL THERAPIES FOR BLOOD-RELATED CANCERS WHERE THERE IS SIGNIFICANT UNMET NEED.

At CTI, we are all deeply connected to each other and our work, united in our quest to improve the lives of patients and their families facing blood-related cancers. Our team holds diverse expertise advancing hematology, oncology and rare disease therapies for patients worldwide, and shares one vision for transforming the future of cancer treatment through scientific excellence and compassion.

OUR CULTURE

• CARE DEEPLY: Work purposefully, guided by compassion for patients and families impacted by rare blood cancers, and one another
• COMMUNICATE OPENLY: Interact with teammates and partners transparently, directly and consistently
• COLLABORATE INCLUSIVELY: Engage with colleagues throughout the organization, recognizing our full team’s success is our own
• COMMIT TENACIOUSLY: Get the job done by believing in the value of our work and collective impact on patients
• ACT WITH INTEGRITY: Demonstrate character by acting with honesty, respect and integrity, always

OUR CULTURE

At CTI we are united by our commitment to patients and are inspired to make a meaningful impact, together.
We start with patients. Our dedicated team shows up every day motivated to make a meaningful difference for people who face blood-related cancers, because we believe in our approach for developing transformative novel therapies. CTI colleagues, no matter their role, all proudly contribute towards our common mission.

At CTI, we have intentionally built a culture that is dynamic, transparent and growth-oriented. With colleagues working in the office and remotely, we recognize the importance of collaboration, communication and connection. We continually look for opportunities to meet, connect, celebrate and support each other. We believe our success is fueled by our team, all of whom embody our core values: Care Deeply, Communicate Openly, Collaborate Inclusively, Commit Tenaciously and Act with Integrity.

DIVERSITY & INCLUSION

We are proud of CTI’s diverse, collaborative and connected culture that encourages everyone to contribute to our goals with compassion and social awareness. CTI is committed to attracting, hiring, retaining and rewarding a diverse workforce. We have prioritized building a culture that fosters understanding, respect and appreciation for diverse viewpoints, expertise and experiences for the many people who now make up our team.

Together we achieve success because of everyone’s contributions, all united by our shared dedication to making a meaningful impact on patients facing blood-related cancers and CTI’s core values.